It could be the world’s first fully approved coronavirus preventivePhase two of trials for a Russian-made coronavirus vaccine will end on August 3, to be immediately followed by a third, international phase.
If successful, it could be the first effective Covid-19 solution to be mass-produced.The vaccine, which has been developed by Moscow’s Gamalei Institute of Epidemiology in conjunction with the Ministry of Defense, will soon begin clinical trials abroad.
“The third phase will not only take place in Russia but also in a number of other countries,” Kirill Dmitriev, head of the Russian Direct Investment Fund (RDIF), told reporters during an online press conference. “We expect to receive regulatory approval to start using the Russian vaccine in August-September.”
On July 15, Russia’s Ministry of Defense announced that, after 28 days of study, no vaccine trialists had experienced “serious adverse side effects, health complaints, complications or adverse reactions.”